Literature DB >> 8343489

Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study.

S A Brown1, R Hutchinson, J Morrisett, E Boerwinkle, C E Davis, A M Gotto, W Patsch.   

Abstract

The distributions of plasma lipids, lipoproteins, and apoproteins of 14,524 female and male black and white participants 45 to 64 years old in the Atherosclerosis Risk in Communities (ARIC) Study are presented. All specimens were analyzed at a central laboratory. Mean total cholesterol levels increased with increasing age across all ages from 204 to 229 mg/dL (12%) in women and from 208 to 213 mg/dL (2%) in men. Triglyceride levels increased with age in women, remained stable in men, and were higher in whites than blacks. High-density lipoprotein (HDL) cholesterol levels were higher in black and white women (range, 57 to 59 mg/dL) compared with black men (49 to 52 mg/dL) or white men (42 to 43 mg/dL). Cholesterol associated with HDL was distributed in a relatively constant proportion between HDL3 (70% to 76%) and HDL2 (24% to 30%) for all race/sex groups. Low-density lipoprotein (LDL) cholesterol levels increased with age in black (14.7%) and white (17.1%) women and in black (4.4%) and white (3.7%) men; more than 50% of all participants had LDL cholesterol levels > 130 mg/dL. Apoprotein A-I and B levels followed the same trends as HDL cholesterol and LDL cholesterol levels, respectively. Lipoprotein(a) [Lp(a)] levels were twice as high in blacks as in whites, and women's Lp(a) levels were higher than men's Lp(a) levels for each race. Menopause was associated with elevated total cholesterol, LDL cholesterol, apoprotein B, and Lp(a) levels, and hormone replacement medication use in postmenopausal subjects was associated with higher HDL cholesterol, triglyceride, and apoprotein A-I levels and lower LDL cholesterol, apoprotein B, and Lp(a) levels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8343489     DOI: 10.1161/01.atv.13.8.1139

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  37 in total

1.  An application of apo(a) isoforms for the clinical assessment of Lp(a).

Authors:  S Takayama; Y Yasumuro; J h Kim; M Ishikawa; D Tsujino; S Matsuo; Y Harada; S Sugii
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 2.  Lipoprotein(a) and coronary heart disease risk.

Authors:  S M Marcovina; R A Hegele; M L Koschinsky
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

3.  Hypercholesterolemia and Dyslipidemia.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-04

4.  Biogeographic ancestry, self-identified race, and admixture-phenotype associations in the Heart SCORE Study.

Authors:  Indrani Halder; Kevin E Kip; Suresh R Mulukutla; Aryan N Aiyer; Oscar C Marroquin; Gordon S Huggins; Steven E Reis
Journal:  Am J Epidemiol       Date:  2012-07-06       Impact factor: 4.897

5.  HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Anna M Kucharska-Newton; Wayne D Rosamond; Jane C Schroeder; Ann Marie McNeill; Josef Coresh; Aaron R Folsom
Journal:  Lung Cancer       Date:  2008-03-14       Impact factor: 5.705

6.  Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the Atherosclerosis Risk in Communities study.

Authors:  Hind Muallem; Kari E North; Masao Kakoki; Mary K Wojczynski; Xia Li; Megan Grove; Eric Boerwinkle; Kirk C Wilhelmsen; Gerardo Heiss; Nobuyo Maeda
Journal:  Hum Genet       Date:  2007-02-02       Impact factor: 4.132

7.  Hypercholesterolemia and Dyslipidemia: Issues for the Clinician.

Authors:  H. Robert Superko; Nicolas A. Chronos
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-02

Review 8.  [Estrogens for prevention of coronary heart disease?].

Authors:  T Meinertz
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

Review 9.  Plasma lipoprotein concentrations in ethnic populations.

Authors:  Karol E Watson
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

10.  Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest.

Authors:  Dan E Arking; Kyndaron Reinier; Wendy Post; Jonathan Jui; Gina Hilton; Ashley O'Connor; Ronald J Prineas; Eric Boerwinkle; Bruce M Psaty; Gordon F Tomaselli; Thomas Rea; Nona Sotoodehnia; David S Siscovick; Gregory L Burke; Eduardo Marban; Peter M Spooner; Aravinda Chakravarti; Sumeet S Chugh
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.